Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 408 institutions that hold shares in the stock, with a total of 188 Million shares, which have been reported (via 13F filing form) to have a value of $10.2 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Viking Global Investors LP
|
Aug 14, 2025 Q2 2025 |
18,555,375
shares
|
$993 Million
2.54% of portfolio
|
Q2 2025
Reduced 15.87%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
16,484,985
shares
|
$882 Million
0.01% of portfolio
|
Q2 2025
Added 10.64%
|
|
|
Kohlberg Kravis Roberts & Co. L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
13,260,971
shares
|
$709 Million
22.63% of portfolio
|
Q2 2025
Reduced 31.15%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
12,448,272
shares
|
$666 Million
0.01% of portfolio
|
Q2 2024
Added 18.93%
|
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
9,276,532
shares
|
$496 Million
0.21% of portfolio
|
Q2 2025
Added 29.35%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
7,900,000
shares
|
$423 Million
1.53% of portfolio
|
Q2 2025
Added 37.85%
|
|
|
Aisling Capital Management LP
New York, NY |
Aug 13, 2025 Q2 2025 |
6,068,125
shares
|
$325 Million
72.84% of portfolio
|
Q1 2021
Added 52.11%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
5,896,596
shares
|
$315 Million
0.01% of portfolio
|
Q2 2025
Added 2.56%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
3,988,298
shares
|
$213 Million
0.04% of portfolio
|
Q2 2025
Reduced 14.55%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
3,800,457
shares
|
$203 Million
8.65% of portfolio
|
Q4 2024
Added 1.06%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
3,681,580
shares
|
$197 Million
0.01% of portfolio
|
Q2 2025
Added 5.1%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
2,812,499
shares
|
$150 Million
0.02% of portfolio
|
Q2 2025
Added 27.93%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
2,801,065
shares
|
$150 Million
0.02% of portfolio
|
Q2 2025
Added 26.97%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
2,621,251
shares
|
$140 Million
0.02% of portfolio
|
Q2 2025
Added 17.9%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,532,716
shares
|
$136 Million
0.05% of portfolio
|
Q2 2023
Added 75.59%
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
2,470,558
shares
|
$132 Million
0.04% of portfolio
|
Q2 2025
Reduced 7.96%
|
|
|
Laurion Capital Management LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,411,248
shares
|
$129 Million
1.94% of portfolio
|
Q2 2025
Reduced 19.04%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,339,067
shares
|
$125 Million
0.2% of portfolio
|
Q2 2025
Added 177.36%
|
|
|
Macquarie Group LTD
Australia, C3 |
Aug 14, 2025 Q2 2025 |
2,095,235
shares
|
$112 Million
0.11% of portfolio
|
Q2 2025
Added 2189.32%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
2,081,253
shares
|
$111 Million
0.07% of portfolio
|
Q2 2025
Added 2403.04%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
1,956,654
shares
|
$105 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
1,891,578
shares
|
$101 Million
0.08% of portfolio
|
Q2 2025
Added 0.2%
|
|
|
Sc Us (Ttgp), Ltd.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
1,860,364
shares
|
$99.5 Million
0.71% of portfolio
|
Q2 2021
Reduced 26.89%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
1,850,039
shares
|
$99 Million
0.13% of portfolio
|
Q1 2025
Reduced 6.34%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
1,807,434
shares
|
$96.7 Million
0.08% of portfolio
|
Q2 2025
Reduced 13.53%
|